{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:11Z","timestamp":1792788011533,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Postdoctoral Fellowship Program of CPSF","award":["GZC20241552"],"award-info":[{"award-number":["GZC20241552"]}]},{"name":"Joint Co-construction Project of Henan Medical Science and Technology Research Program","award":["LHGJ20240277"],"award-info":[{"award-number":["LHGJ20240277"]}]},{"name":"Youth Fund Project of Natural Science Foundation of Henan Province","award":["252300420529"],"award-info":[{"award-number":["252300420529"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06682-1","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T07:47:44Z","timestamp":1750146464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pathway-based cancer transcriptome deciphers a high-resolution intrinsic heterogeneity within bladder cancer classification"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"10364","key":"6682_CR1","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400(10364):1712\u201321.","journal-title":"Lancet"},{"issue":"1","key":"6682_CR2","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1038\/s41598-024-61302-0","volume":"14","author":"G Cheng","year":"2024","unstructured":"Cheng G, et al. Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genes. Sci Rep. 2024;14(1):10482.","journal-title":"Sci Rep"},{"issue":"8","key":"6682_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","volume":"16","author":"C Alifrangis","year":"2019","unstructured":"Alifrangis C, et al. Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol. 2019;16(8):465\u201383.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"6682_CR4","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1111\/cas.16275","volume":"115","author":"B Akman","year":"2024","unstructured":"Akman B, et al. Nucleocytoplasmic \u03b2-catenin expression contributes to neuroendocrine differentiation in muscle invasive bladder cancer. Cancer Sci. 2024;115(9):2985\u201397.","journal-title":"Cancer Sci"},{"issue":"19","key":"6682_CR5","doi-asserted-by":"publisher","first-page":"e70111","DOI":"10.1111\/jcmm.70111","volume":"28","author":"S Li","year":"2024","unstructured":"Li S, et al. Integrated analysis of bulk and single-cell RNA-seq data reveals cell differentiation-related subtypes and a scoring system in bladder cancer. J Cell Mol Med. 2024;28(19):e70111.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"6682_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.eururo.2015.07.021","volume":"68","author":"M Aine","year":"2015","unstructured":"Aine M, et al. On molecular classification of bladder cancer: out of one, many. Eur Urol. 2015;68(6):921\u20133.","journal-title":"Eur Urol"},{"issue":"1","key":"6682_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/BLC-150037","volume":"2","author":"SP Lerner","year":"2016","unstructured":"Lerner SP, et al. Bladder Cancer molecular taxonomy: summary from a consensus meeting. Bladder Cancer. 2016;2(1):37\u201347.","journal-title":"Bladder Cancer"},{"issue":"1","key":"6682_CR8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog SV, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021;12(1):2301.","journal-title":"Nat Commun"},{"issue":"4","key":"6682_CR9","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s12539-024-00641-y","volume":"16","author":"H Chai","year":"2024","unstructured":"Chai H, et al. A Contrastive-Learning-Based deep neural network for Cancer subtyping by integrating Multi-Omics data. Interdiscip Sci. 2024;16(4):966\u201375.","journal-title":"Interdiscip Sci"},{"issue":"3","key":"6682_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","volume":"75","author":"TZ Tan","year":"2019","unstructured":"Tan TZ, et al. Molecular subtypes of urothelial bladder cancer: results from a Meta-cohort analysis of 2411 tumors. Eur Urol. 2019;75(3):423\u201332.","journal-title":"Eur Urol"},{"issue":"1","key":"6682_CR11","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077.","journal-title":"Nat Commun"},{"key":"6682_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2017.07.003","volume":"59","author":"E Hedlund","year":"2018","unstructured":"Hedlund E, Deng Q. Single-cell RNA sequencing: technical advancements and biological applications. Mol Aspects Med. 2018;59:36\u201346.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"6682_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","volume":"2","author":"L Garofano","year":"2021","unstructured":"Garofano L, et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat Cancer. 2021;2(2):141\u201356.","journal-title":"Nat Cancer"},{"key":"6682_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1745-6150-7-21","volume":"7","author":"S Kim","year":"2012","unstructured":"Kim S, Kon M, DeLisi C. Pathway-based classification of cancer subtypes. Biol Direct. 2012;7:21.","journal-title":"Biol Direct"},{"key":"6682_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov A, et al. SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med Genomics. 2010;3:21.","journal-title":"BMC Med Genomics"},{"key":"6682_CR16","doi-asserted-by":"crossref","unstructured":"Becht E, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol; 2018.","DOI":"10.1038\/nbt.4314"},{"issue":"12","key":"6682_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149(12):2099\u2013115.","journal-title":"Int J Cancer"},{"issue":"12","key":"6682_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, et al. Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550\u2013e15657.","journal-title":"Cancer Cell"},{"issue":"1","key":"6682_CR19","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/s41467-022-34495-z","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, et al. Single cell sequencing reveals that CD39 Inhibition mediates changes to the tumor microenvironment. Nat Commun. 2022;13(1):6740.","journal-title":"Nat Commun"},{"issue":"1","key":"6682_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"6190","key":"6682_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396\u2013401.","journal-title":"Science"},{"issue":"10","key":"6682_CR22","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/S2589-7500(23)00135-8","volume":"5","author":"P Saux","year":"2023","unstructured":"Saux P, et al. Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study. Lancet Digit Health. 2023;5(10):e692\u2013702.","journal-title":"Lancet Digit Health"},{"key":"6682_CR23","doi-asserted-by":"crossref","unstructured":"Dai M, Pei X, Wang XJ. Accurate and fast cell marker gene identification with COSG. Brief Bioinform, 2022. 23(2).","DOI":"10.1093\/bib\/bbab579"},{"issue":"11","key":"6682_CR24","doi-asserted-by":"publisher","first-page":"e15543","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE. 2010;5(11):e15543.","journal-title":"PLoS ONE"},{"key":"6682_CR25","doi-asserted-by":"publisher","first-page":"110774","DOI":"10.1016\/j.cellsig.2023.110774","volume":"109","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, et al. Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer. Cell Signal. 2023;109:110774.","journal-title":"Cell Signal"},{"issue":"1","key":"6682_CR26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"key":"6682_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"6682_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"key":"6682_CR29","doi-asserted-by":"publisher","first-page":"669694","DOI":"10.3389\/fgene.2021.669694","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. Association of RYR2 mutation with tumor mutation burden, prognosis, and antitumor immunity in patients with esophageal adenocarcinoma. Front Genet. 2021;12:669694.","journal-title":"Front Genet"},{"issue":"7","key":"6682_CR30","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/jcmm.16393","volume":"25","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. TTN\/OBSCN \u2018Double-Hit\u2019 predicts favourable prognosis, \u2018immune-hot\u2019 subtype and potentially better immunotherapeutic efficacy in colorectal cancer. J Cell Mol Med. 2021;25(7):3239\u201351.","journal-title":"J Cell Mol Med"},{"key":"6682_CR31","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.2147\/JIR.S414452","volume":"16","author":"T Luan","year":"2023","unstructured":"Luan T, et al. Identification and analysis of neutrophil extracellular Trap-Related genes in osteoarthritis by bioinformatics and experimental verification. J Inflamm Res. 2023;16:3837\u201352.","journal-title":"J Inflamm Res"},{"key":"6682_CR32","doi-asserted-by":"publisher","first-page":"1162458","DOI":"10.3389\/fimmu.2023.1162458","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis. Front Immunol. 2023;14:1162458.","journal-title":"Front Immunol"},{"key":"6682_CR33","doi-asserted-by":"publisher","first-page":"1030198","DOI":"10.3389\/fimmu.2023.1030198","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198.","journal-title":"Front Immunol"},{"issue":"11","key":"6682_CR34","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2019040335","volume":"30","author":"Z Yu","year":"2019","unstructured":"Yu Z, et al. Single-Cell transcriptomic map of the human and mouse bladders. J Am Soc Nephrol. 2019;30(11):2159\u201376.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"6682_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2020.05.010","volume":"52","author":"J Le","year":"2020","unstructured":"Le J, et al. Single-Cell RNA-Seq mapping of human thymopoiesis reveals lineage specification trajectories and a commitment spectrum in T cell development. Immunity. 2020;52(6):1105\u2013e11189.","journal-title":"Immunity"},{"issue":"6","key":"6682_CR36","doi-asserted-by":"publisher","first-page":"111606","DOI":"10.1016\/j.celrep.2022.111606","volume":"41","author":"C Guo","year":"2022","unstructured":"Guo C, et al. Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4\u2009+\u2009T cell subset in systemic lupus erythematosus. Cell Rep. 2022;41(6):111606.","journal-title":"Cell Rep"},{"issue":"14","key":"6682_CR37","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.7150\/thno.21471","volume":"7","author":"YP Chen","year":"2017","unstructured":"Chen YP, et al. Genomic analysis of tumor microenvironment immune types across 14 solid Cancer types: immunotherapeutic implications. Theranostics. 2017;7(14):3585\u201394.","journal-title":"Theranostics"},{"key":"6682_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pathol-012513-104703","volume":"11","author":"B Czerniak","year":"2016","unstructured":"Czerniak B, Dinney C, McConkey D. Origins of bladder Cancer. Annu Rev Pathol. 2016;11:149\u201374.","journal-title":"Annu Rev Pathol"},{"key":"6682_CR39","doi-asserted-by":"publisher","first-page":"782982","DOI":"10.3389\/fimmu.2022.782982","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. Pyroptosis-Related signature predicts prognosis and immunotherapy efficacy in Muscle-Invasive bladder Cancer. Front Immunol. 2022;13:782982.","journal-title":"Front Immunol"},{"issue":"10","key":"6682_CR40","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41418-019-0278-9","volume":"26","author":"S Ramakrishnan","year":"2019","unstructured":"Ramakrishnan S, et al. Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ. 2019;26(10):2100\u201314.","journal-title":"Cell Death Differ"},{"key":"6682_CR41","doi-asserted-by":"crossref","unstructured":"Wang S et al. Antigen Presentation Tumor Immunogenicity cancer Immunotherapy Response Prediction Elife, 2019. 8.","DOI":"10.7554\/eLife.49020"},{"issue":"1","key":"6682_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","volume":"6","author":"P Danaher","year":"2018","unstructured":"Danaher P, et al. Pan-cancer adaptive immune resistance as defined by the tumor inflammation signature (TIS): results from the Cancer genome atlas (TCGA). J Immunother Cancer. 2018;6(1):63.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"6682_CR43","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"key":"6682_CR44","doi-asserted-by":"crossref","unstructured":"Jew B et al. Accurate estimation of cell composition in bulk expression through robust integration of single-cell information. Nat Commun, 2020. 11(1): p. 1971.","DOI":"10.1038\/s41467-020-15816-6"},{"issue":"1","key":"6682_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6682_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"7679","key":"6682_CR47","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/551S33a","volume":"551","author":"M Grayson","year":"2017","unstructured":"Grayson M. Bladder cancer. Nature. 2017;551(7679):S33.","journal-title":"Nature"},{"issue":"1","key":"6682_CR48","doi-asserted-by":"publisher","first-page":"e3580","DOI":"10.1002\/jgm.3580","volume":"26","author":"Z Li","year":"2024","unstructured":"Li Z, et al. Multi-omics analysis reveals that ferroptosis-related gene CISD2 is a prognostic biomarker of head and neck squamous cell carcinoma. J Gene Med. 2024;26(1):e3580.","journal-title":"J Gene Med"},{"issue":"1","key":"6682_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021;40(1):81.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6682_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12539-023-00587-7","volume":"16","author":"Y Xu","year":"2024","unstructured":"Xu Y, et al. Combining Global-Constrained concept factorization and a regularized Gaussian graphical model for clustering Single-Cell RNA-seq data. Interdiscip Sci. 2024;16(1):1\u201315.","journal-title":"Interdiscip Sci"},{"issue":"3","key":"6682_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/med4.34","volume":"1","author":"X Long","year":"2023","unstructured":"Long X, Yan B, Mo Z. Uncovering the heterogeneity and cell fate decisions of endothelial cells after myocardial infarction by single-cell sequencing. Med Adv. 2023;1(3):234\u201345.","journal-title":"Med Adv"},{"issue":"1","key":"6682_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/med4.10","volume":"1","author":"M Yang","year":"2023","unstructured":"Yang M, et al. Single-cell RNA sequencing reveals distinct immune cell subsets in phalangeal and soft-tissue recurrence of giant cell tumor of bone. Med Adv. 2023;1(1):14\u201329.","journal-title":"Med Adv"},{"issue":"1","key":"6682_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan Z, et al. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J Transl Med. 2023;21(1):223.","journal-title":"J Transl Med"},{"issue":"3","key":"6682_CR54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12539-024-00627-w","volume":"16","author":"Q Feng","year":"2024","unstructured":"Feng Q, et al. Identifying diffuse glioma subtypes based on pathway enrichment evaluation. Interdiscip Sci. 2024;16(3):727\u201340.","journal-title":"Interdiscip Sci"},{"issue":"6","key":"6682_CR55","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3892\/ol.2021.13072","volume":"22","author":"Y Luo","year":"2021","unstructured":"Luo Y, et al. Emerging role of BAD and DAD1 as potential targets and biomarkers in cancer. Oncol Lett. 2021;22(6):811.","journal-title":"Oncol Lett"},{"issue":"1","key":"6682_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7150\/thno.88550","volume":"14","author":"D Tang","year":"2024","unstructured":"Tang D, et al. Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy. Theranostics. 2024;14(1):203\u201319.","journal-title":"Theranostics"},{"key":"6682_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2023.01.001","volume":"354","author":"P Zhang","year":"2023","unstructured":"Zhang P, et al. Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer. J Control Release. 2023;354:69\u201379.","journal-title":"J Control Release"},{"issue":"16","key":"6682_CR58","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.7150\/jca.42669","volume":"11","author":"A Alsubait","year":"2020","unstructured":"Alsubait A, et al. CYP1B1 gene: implications in glaucoma and cancer. J Cancer. 2020;11(16):4652\u201361.","journal-title":"J Cancer"},{"issue":"1","key":"6682_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2012.04.021","volume":"324","author":"K Gajjar","year":"2012","unstructured":"Gajjar K, Martin-Hirsch PL, Martin FL. CYP1B1 and hormone-induced cancer. Cancer Lett. 2012;324(1):13\u201330.","journal-title":"Cancer Lett"},{"key":"6682_CR60","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1186\/s12885-015-1951-0","volume":"15","author":"Y Mitsui","year":"2015","unstructured":"Mitsui Y, et al. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015;15:942.","journal-title":"BMC Cancer"},{"issue":"6","key":"6682_CR61","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1261\/rna.070557.119","volume":"25","author":"LY Chu","year":"2019","unstructured":"Chu LY, et al. Structural insights into NanoRNA degradation by human Rexo2. RNA. 2019;25(6):737\u201346.","journal-title":"RNA"},{"issue":"10","key":"6682_CR62","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1093\/nar\/gkaa302","volume":"48","author":"M Szewczyk","year":"2020","unstructured":"Szewczyk M, et al. Human REXO2 controls short mitochondrial RNAs generated by MtRNA processing and decay machinery to prevent accumulation of double-stranded RNA. Nucleic Acids Res. 2020;48(10):5572\u201390.","journal-title":"Nucleic Acids Res"},{"key":"6682_CR63","doi-asserted-by":"publisher","first-page":"111740","DOI":"10.1016\/j.intimp.2024.111740","volume":"130","author":"T Zhang","year":"2024","unstructured":"Zhang T, et al. REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Int Immunopharmacol. 2024;130:111740.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6682_CR64","doi-asserted-by":"publisher","first-page":"11836","DOI":"10.1038\/s41598-021-91382-1","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H, et al. RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma. Sci Rep. 2021;11(1):11836.","journal-title":"Sci Rep"},{"key":"6682_CR65","doi-asserted-by":"publisher","first-page":"591667","DOI":"10.3389\/fgene.2020.591667","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua X, et al. Effects of RNA binding proteins on the prognosis and malignant progression in prostate Cancer. Front Genet. 2020;11:591667.","journal-title":"Front Genet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06682-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:02:26Z","timestamp":1750150946000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06682-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6682"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06682-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples procedures were approved by the Ethics Committee of Zhengzhou University\u2019s First Affiliated Hospital (2024-KY-1687).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All Authors have seen and approved the manuscript and consent publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"666"}}